Serum HE4 and CA-125 in Relation to Oxidative Stress and Antioxidant Status in Women with Benign and Malignant Ovarian Tumors

Background: Clinical examination alone is still challenging to differentiate ovarian cancer from benign ovarian illness. In this study, we assessed the combined use of tumor markers HE4 and CA-125 with oxidative-stress indicators in an effort to obtain a wider biochemical profile of ovarian illness. Materials and Methods: The case-control study consisted of 105 women, 35 women in each of three groups: healthy controls, benign ovarian tumor patients, and women with stage III, grade 3 ovarian cancer. Serum HE4 and CA-125 were tested by ELISA kits. Total oxidant status (TOS), total antioxidant capacity (TAC) and malondialdehyde (MDA) were measured by colorimetric method and oxidative stress index (OSI) was computed from TOS and TAC. We assessed group comparisons, receiver operating characteristic analysis, correlations and odds ratios. Results: In controls, the level of HE4 was 27.42 ± 5.21 pmol/L, in benign illness 58.64 ± 8.63 pmol/L and in malignancy 183.32 ± 41.93 pmol/L. CA-125 rose from 11.95 ± 1.79 to 80.28 ± 17.54 to 548.83 ± 93.55 U/mL. TOS, MDA and OSI showed a gradual increase but TAC showed a substantial decrease among groups (P<0.001). CA-125 and HE4 had excellent discriminating between malignant and benign illness with AUCs of 1.000 and 0.998, respectively; OSI also performed well (AUC=0.941). Tumor markers were positively connected with oxidant indicators and negatively correlated with TAC. Discussion: The results show a gradual transition from the healthy status to the benign disease and advanced malignancy with increasing values of tumor markers and increased oxidative imbalance. We suggest that integration of tumor related and redox indicators may give supplementary information on ovarian disease severity. These results favor integrated assessment over dependence on a single circulating marker.

Authors

Institutions

Publication Details

Journal
NIU Journal of Health Sciences
Published
2026-11-16
DOI
https://doi.org/10.58709/niujhs.v12i3.2772
Primary Topic
Ovarian cancer diagnosis and treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Serum HE4 and CA-125 in Relation to Oxidative Stress and Antioxidant Status in Women with Benign and Malignant Ovarian Tumors

Zahraa Ali Jaafar
NIU Journal of Health Sciences
Ovarian cancer diagnosis and treatment
article

Serum HE4 and CA-125 in Relation to Oxidative Stress and Antioxidant Status in Women with Benign and Malignant Ovarian Tumors

Zahraa Ali Jaafar
article en

Abstract

Background: Clinical examination alone is still challenging to differentiate ovarian cancer from benign ovarian illness. In this study, we assessed the combined use of tumor markers HE4 and CA-125 with oxidative-stress indicators in an effort to obtain a wider biochemical profile of ovarian illness. Materials and Methods: The case-control study consisted of 105 women, 35 women in each of three groups: healthy controls, benign ovarian tumor patients, and women with stage III, grade 3 ovarian cancer. Serum HE4 and CA-125 were tested by ELISA kits. Total oxidant status (TOS), total antioxidant capacity (TAC) and malondialdehyde (MDA) were measured by colorimetric method and oxidative stress index (OSI) was computed from TOS and TAC. We assessed group comparisons, receiver operating characteristic analysis, correlations and odds ratios. Results: In controls, the level of HE4 was 27.42 ± 5.21 pmol/L, in benign illness 58.64 ± 8.63 pmol/L and in malignancy 183.32 ± 41.93 pmol/L. CA-125 rose from 11.95 ± 1.79 to 80.28 ± 17.54 to 548.83 ± 93.55 U/mL. TOS, MDA and OSI showed a gradual increase but TAC showed a substantial decrease among groups (P<0.001). CA-125 and HE4 had excellent discriminating between malignant and benign illness with AUCs of 1.000 and 0.998, respectively; OSI also performed well (AUC=0.941). Tumor markers were positively connected with oxidant indicators and negatively correlated with TAC. Discussion: The results show a gradual transition from the healthy status to the benign disease and advanced malignancy with increasing values of tumor markers and increased oxidative imbalance. We suggest that integration of tumor related and redox indicators may give supplementary information on ovarian disease severity. These results favor integrated assessment over dependence on a single circulating marker.

NIU Journal of Health SciencesVol. 12(3)
Iraqi University (IQ), Iraq University College (IQ)
Good health and well-being
Ovarian cancer diagnosis and treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon